Alector, Inc. Common Stock (ALEC) is a publicly traded Healthcare sector company. As of May 21, 2026, ALEC trades at $2.12 with a market cap of $235.37M and a P/E ratio of -1.84. ALEC moved +0.47% today. Year to date, ALEC is +32.50%; over the trailing twelve months it is +54.74%. Its 52-week range spans $0.87 to $6.14. Analyst consensus is neutral with an average price target of $3.63. Rallies surfaces ALEC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alector Ends Q1 with $206.5M Runway, Revenue Drops 73% to $1M: Alector ended Q1 with $206.5M cash runway into at least 2027 and saw collaboration revenue fall to $1.0M from $3.7M year-over-year. R&D expenses halved to $17.9M and G&A dropped to $8.1M, reflecting the recent reduction in force.
| Metric | Value |
|---|---|
| Price | $2.12 |
| Market Cap | $235.37M |
| P/E Ratio | -1.84 |
| EPS | $-1.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.14 |
| 52-Week Low | $0.87 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $18.42M |
| Net Income | $-125.39M |
| Gross Margin | 0.00% |
8 analysts cover ALEC: 0 strong buy, 3 buy, 3 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $3.63.